Peter Olah
Overview
Explore the profile of Peter Olah including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
530
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Smola A, Hawerkamp H, Olah P, Kislat A, Duschner N, Homey B, et al.
Immun Inflamm Dis
. 2025 Feb;
13(2):e70132.
PMID: 39935189
Background: Chronic spontaneous urticaria (CSU) is a debilitating inflammatory skin disease with a prevalence of approximately 1% of the population. It is characterized by recurrent itchy wheals and/or angioedema for...
2.
Pozsgai M, Sebastian U, Olah P, Nemeth V, Gyulai R, Lengyel Z
Int J Dermatol
. 2025 Feb;
PMID: 39925013
Background: The introduction of immune checkpoint inhibitors (ICIs) opened a new era in cancer immunotherapy. In particular, PD-1 inhibitors have shown remarkable efficacy in various cancers, most notably melanoma. However,...
3.
Tombacz D, Maroti Z, Olah P, Dormo A, Gulyas G, Kalmar T, et al.
Sci Rep
. 2025 Jan;
15(1):3247.
PMID: 39863683
In our research, we performed temporal transcriptomic profiling of host cells infected with Equid alphaherpesvirus 1 (EHV-1) by utilizing direct cDNA sequencing based on nanopore MinION technology. The sequencing reads...
4.
Sinkko H, Olah P, Yang Y, Maia G, Barrientos-Somarribas M, Radai Z, et al.
Br J Dermatol
. 2024 Dec;
PMID: 39657723
No abstract available.
5.
Yang Y, Olah P, Radai Z, Maia G, Salava A, Salo V, et al.
EBioMedicine
. 2024 Jun;
105:105222.
PMID: 38924840
Background: Psoriasis (Pso) is a chronic inflammatory skin disease that poses both physical and psychological challenges. Dysbiosis of the skin microbiome has been implicated in Pso, yet a comprehensive multi-omics...
6.
Cojocaru C, Popa C, Schenk A, Jakab Z, Suciu B, Olah P, et al.
Behav Sci (Basel)
. 2024 Apr;
14(4).
PMID: 38667123
Background And Objectives: Defined by chronic pain, rheumatic diseases are often co-occurring with anxiety and depression. Among the available psychological interventions, cognitive-behavioral therapies have an already-proven efficiency in these cases....
7.
Rikken G, Meesters L, Jansen P, Rodijk-Olthuis D, van Vlijmen-Willems I, Niehues H, et al.
Microbiome
. 2023 Oct;
11(1):227.
PMID: 37849006
Background: Following descriptive studies on skin microbiota in health and disease, mechanistic studies on the interplay between skin and microbes are on the rise, for which experimental models are in...
8.
Aevermann B, Di Domizio J, Olah P, Saidoune F, Armstrong J, Bachelez H, et al.
J Invest Dermatol
. 2023 Aug;
144(2):252-262.e4.
PMID: 37598867
Tissue transcriptomics is used to uncover molecular dysregulations underlying diseases. However, the majority of transcriptomics studies focus on single diseases with limited relevance for understanding the molecular relationship between diseases...
9.
Kislat A, Olah P, Kuchner M, Gerber P, Schrader J, Meller S, et al.
Int J Mol Sci
. 2023 Jun;
24(11).
PMID: 37298605
Retinoids are a frequently used class of drugs in the treatment of inflammatory as well as malignant skin diseases. Retinoids have differential affinity for the retinoic acid receptor (RAR) and/or...
10.
Pop A, Monea M, Olah P, Moraru R, Cotoi O
Diagnostics (Basel)
. 2023 Mar;
13(6).
PMID: 36980327
Primary cutaneous melanoma (PCM) is the most aggressive skin malignancy, with an increasing incidence and significant mortality. Tumoral invasion, expressed as Breslow thickness, is routinely assessed on hematoxylin and eosin...